August 14, 2026 U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
August 14, 2026 Peer To Peer Network (OTC: PTOP) Expands Digital Technology Platform With MobiCard™ and New AI-Powered Synaptic Quant
August 14, 2026 Where Can Founders Sell an Unfinished Online Business? useEmark.com Expands Its Private-Beta Marketplace
When Prophecy Replaces Accountability!
When Prophecy Replaces Accountability! 
